Literature DB >> 23128542

Determinants of coronary collateral circulation in patients with coronary artery disease.

Cafer Zorkun1, Emre Akkaya, Ali Zorlu, Izzet Tandoğan.   

Abstract

OBJECTIVE: This study aims to identify possible determinants of coronary collaterals in patients with severe coronary artery disease.
METHODS: The current study has a retrospective cohort design. Seventy four patients with ≥90% stenosis or total occlusion of the left anterior descending artery (LAD) were enrolled; coronary collateral grades, high-sensitive C-reactive protein (hs-CRP), fibrinogen, protein C and S, lipids, uric acid levels and medications applied before coronary angiography were noted and compared. Multiple logistic regression analysis was used for the multivariate analyses of independent variables associated with the development of adequate coronary collateral vessels.
RESULTS: The presence of coronary collaterals was significantly higher in males (p=0.018), with higher hs-CRP (p=0.023), prior statin use (p=0.022), and higher Gensini scores (p<0.001). In multiple logistic regression analysis, hs-CRP levels (OR=0.94, 95.0% CI=0.883-1.000, p=0.048), male gender (OR=4.73, 95.0% CI=1.441-15.539, p=0.010) and prior statin usage (OR=4.70, 95.0% CI=1.264-17.452, p=0.021) were identified as independent predictors of coronary collateral development.
CONCLUSION: Male gender, prior statin usage, and higher hs-CRP levels are determinants of coronary collaterals in patients with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23128542     DOI: 10.5152/akd.2012.250

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  8 in total

1.  Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion.

Authors:  Zhen Sun; Ying Shen; Lin Lu; Rui-yan Zhang; Li-jin Pu; Qi Zhang; Zheng-kun Yang; Jian Hu; Qiu-jing Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

2.  Prognostic Nutritional Index as a New Prediction Tool for Coronary Collateral Development.

Authors:  Kürşat Akbuğa; Özge Kurmuş Ferik; Kadriye Gayretli Yayla; Turgay Aslan; Murat Eren; Mustafa Karanfil; Berkay Ekici; Aycan Fahri Erkan; Ebru Akgül Ercan; Celal Kervancioğlu
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

3.  Plasma Omentin-1 Level as a Predictor of Good Coronary Collateral Circulation.

Authors:  Ji-Peng Zhou; Xiao-Yu Tong; Ling-Ping Zhu; Jing-Min Luo; Ying Luo; Yong-Ping Bai; Chuan-Chang Li; Guo-Gang Zhang
Journal:  J Atheroscler Thromb       Date:  2017-01-25       Impact factor: 4.928

4.  Predictors of poor coronary collateral development in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets.

Authors:  Fatih Akın; Burak Ayça; Ömer Çelik; Cem Şahin
Journal:  Anatol J Cardiol       Date:  2014-04-08       Impact factor: 1.596

5.  Does the extent of collaterals influence the severity of the myocardial injury as assessed by elevation in biomarkers?

Authors:  Gajendra Dubey; Kamal Sharma; Iva Patel; Zeeshan Mansuri; Vishal Sharma
Journal:  J Cardiovasc Thorac Res       Date:  2021-01-28

6.  Influence of Obstructive Sleep Apnoea Severity on Coronary Collateral Recruitment During Coronary Occlusion.

Authors:  Usaid K Allahwala; Peter A Cistulli; Hasthi U Dissanayake; Michael Ward; James C Weaver; Ravinay Bhindi
Journal:  Lung       Date:  2021-08-10       Impact factor: 2.584

7.  Predictors of coronary collaterals in patients with non ST-elevated acute coronary syndrome: the paradox of the leukocytes.

Authors:  Erhan Tenekecioglu; Mustafa Yılmaz; Kemal Karaagac; Adem Bekler; Burhan Aslan; Serafettin Demir; Mustafa Kuzeytemiz
Journal:  Cent Eur J Immunol       Date:  2014-04-17       Impact factor: 2.085

8.  Blood Group Types O and Non-O Are Associated With Coronary Collateral Circulation Development.

Authors:  Savas Celebi; Ozlem Ozcan Celebi; Berkten Berkalp; Sinan Aydogdu; Basri Amasyali
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.